vs

Side-by-side financial comparison of Apyx Medical Corp (APYX) and Arena Group Holdings, Inc. (AREN). Click either name above to swap in a different company.

Arena Group Holdings, Inc. is the larger business by last-quarter revenue ($28.2M vs $19.2M, roughly 1.5× Apyx Medical Corp). Arena Group Holdings, Inc. runs the higher net margin — 18.9% vs -6.8%, a 25.7% gap on every dollar of revenue. On growth, Apyx Medical Corp posted the faster year-over-year revenue change (34.7% vs -22.0%). Over the past eight quarters, Apyx Medical Corp's revenue compounded faster (36.8% CAGR vs -1.2%).

Bovie Medical Corporation was an American medical device manufacturer of medical devices, electrosurgical products and energy technologies. It was based in Clearwater, Florida with a manufacturing facility in Bulgaria.

Arena Racing Company, also called ARC Racing and Leisure Group is a UK private company, created in 2012 by the merger of Arena Leisure and Northern Racing. It owns and operates 16 racecourses in Great Britain, accounting for 39% of British racing fixtures. It also operates hotels at Wolverhampton Racecourse, Lingfield Park Racecourse and Doncaster Racecourse and golf courses at Lingfield, Southwell and Newcastle.

APYX vs AREN — Head-to-Head

Bigger by revenue
AREN
AREN
1.5× larger
AREN
$28.2M
$19.2M
APYX
Growing faster (revenue YoY)
APYX
APYX
+56.8% gap
APYX
34.7%
-22.0%
AREN
Higher net margin
AREN
AREN
25.7% more per $
AREN
18.9%
-6.8%
APYX
Faster 2-yr revenue CAGR
APYX
APYX
Annualised
APYX
36.8%
-1.2%
AREN

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
APYX
APYX
AREN
AREN
Revenue
$19.2M
$28.2M
Net Profit
$-1.3M
$5.3M
Gross Margin
62.6%
43.6%
Operating Margin
0.1%
26.6%
Net Margin
-6.8%
18.9%
Revenue YoY
34.7%
-22.0%
Net Profit YoY
71.9%
-22.5%
EPS (diluted)
$0.12

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
APYX
APYX
AREN
AREN
Q4 25
$19.2M
$28.2M
Q3 25
$12.9M
$29.8M
Q2 25
$11.4M
$45.0M
Q1 25
$9.4M
$31.8M
Q4 24
$14.2M
$36.2M
Q3 24
$11.5M
$33.6M
Q2 24
$12.1M
$27.2M
Q1 24
$10.2M
$28.9M
Net Profit
APYX
APYX
AREN
AREN
Q4 25
$-1.3M
$5.3M
Q3 25
$-2.0M
$6.9M
Q2 25
$-3.8M
$108.6M
Q1 25
$-4.2M
$4.0M
Q4 24
$-4.6M
$6.9M
Q3 24
$-4.7M
$4.0M
Q2 24
$-6.6M
$-8.2M
Q1 24
$-7.6M
$-103.4M
Gross Margin
APYX
APYX
AREN
AREN
Q4 25
62.6%
43.6%
Q3 25
64.4%
50.2%
Q2 25
62.3%
56.5%
Q1 25
60.1%
49.3%
Q4 24
63.0%
52.6%
Q3 24
60.5%
50.6%
Q2 24
61.7%
39.4%
Q1 24
58.1%
30.9%
Operating Margin
APYX
APYX
AREN
AREN
Q4 25
0.1%
26.6%
Q3 25
-6.5%
31.9%
Q2 25
-22.6%
36.5%
Q1 25
-32.4%
23.1%
Q4 24
-21.4%
28.6%
Q3 24
-31.6%
24.0%
Q2 24
-45.7%
-9.5%
Q1 24
-64.6%
-27.5%
Net Margin
APYX
APYX
AREN
AREN
Q4 25
-6.8%
18.9%
Q3 25
-15.4%
23.1%
Q2 25
-33.2%
241.4%
Q1 25
-44.0%
12.6%
Q4 24
-32.5%
19.0%
Q3 24
-40.9%
11.8%
Q2 24
-54.0%
-30.1%
Q1 24
-74.0%
-357.1%
EPS (diluted)
APYX
APYX
AREN
AREN
Q4 25
$0.12
Q3 25
$0.14
Q2 25
$2.28
Q1 25
$0.08
Q4 24
$1.23
Q3 24
$0.11
Q2 24
$-0.19
$-0.28
Q1 24
$-0.22
$-3.91

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
APYX
APYX
AREN
AREN
Cash + ST InvestmentsLiquidity on hand
$31.7M
$10.3M
Total DebtLower is stronger
$37.5M
$97.6M
Stockholders' EquityBook value
$14.5M
$-4.8M
Total Assets
$66.8M
$112.6M
Debt / EquityLower = less leverage
2.58×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
APYX
APYX
AREN
AREN
Q4 25
$31.7M
$10.3M
Q3 25
$25.1M
$12.5M
Q2 25
$29.3M
$6.8M
Q1 25
$31.0M
$2.9M
Q4 24
$31.7M
$4.4M
Q3 24
$28.0M
$5.8M
Q2 24
$32.7M
$6.1M
Q1 24
$37.3M
$4.0M
Total Debt
APYX
APYX
AREN
AREN
Q4 25
$37.5M
$97.6M
Q3 25
$37.5M
$110.5M
Q2 25
$37.5M
$110.5M
Q1 25
$37.5M
$110.5M
Q4 24
$37.5M
$110.4M
Q3 24
$37.5M
$102.4M
Q2 24
$102.4M
Q1 24
$102.3M
Stockholders' Equity
APYX
APYX
AREN
AREN
Q4 25
$14.5M
$-4.8M
Q3 25
$5.8M
$-10.4M
Q2 25
$7.3M
$-17.3M
Q1 25
$10.5M
$-126.1M
Q4 24
$14.2M
$-130.3M
Q3 24
$11.0M
$-137.5M
Q2 24
$14.7M
$-157.2M
Q1 24
$20.3M
$-149.6M
Total Assets
APYX
APYX
AREN
AREN
Q4 25
$66.8M
$112.6M
Q3 25
$57.4M
$121.4M
Q2 25
$58.2M
$127.8M
Q1 25
$60.2M
$114.6M
Q4 24
$64.8M
$116.4M
Q3 24
$60.7M
$114.2M
Q2 24
$65.4M
$113.4M
Q1 24
$70.7M
$120.3M
Debt / Equity
APYX
APYX
AREN
AREN
Q4 25
2.58×
Q3 25
6.41×
Q2 25
5.17×
Q1 25
3.57×
Q4 24
2.64×
Q3 24
3.40×
Q2 24
Q1 24

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
APYX
APYX
AREN
AREN
Operating Cash FlowLast quarter
$-2.5M
$13.1M
Free Cash FlowOCF − Capex
$-2.8M
FCF MarginFCF / Revenue
-14.6%
Capex IntensityCapex / Revenue
1.4%
Cash ConversionOCF / Net Profit
2.46×
TTM Free Cash FlowTrailing 4 quarters
$-9.1M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
APYX
APYX
AREN
AREN
Q4 25
$-2.5M
$13.1M
Q3 25
$-3.5M
$12.2M
Q2 25
$-1.2M
$10.3M
Q1 25
$-702.0K
$3.7M
Q4 24
$-2.9M
$-8.6M
Q3 24
$-4.4M
$-2.3M
Q2 24
$-4.3M
$-3.2M
Q1 24
$-6.3M
$-2.0M
Free Cash Flow
APYX
APYX
AREN
AREN
Q4 25
$-2.8M
Q3 25
$-4.1M
Q2 25
$-1.5M
Q1 25
$-757.0K
Q4 24
$-3.2M
Q3 24
$-4.6M
$-2.4M
Q2 24
$-4.6M
Q1 24
$-6.4M
FCF Margin
APYX
APYX
AREN
AREN
Q4 25
-14.6%
Q3 25
-31.5%
Q2 25
-13.2%
Q1 25
-8.0%
Q4 24
-22.4%
Q3 24
-40.0%
-7.1%
Q2 24
-38.0%
Q1 24
-62.2%
Capex Intensity
APYX
APYX
AREN
AREN
Q4 25
1.4%
Q3 25
4.0%
0.0%
Q2 25
2.3%
Q1 25
0.6%
Q4 24
1.7%
Q3 24
1.3%
0.1%
Q2 24
2.4%
Q1 24
0.3%
Cash Conversion
APYX
APYX
AREN
AREN
Q4 25
2.46×
Q3 25
1.77×
Q2 25
0.09×
Q1 25
0.91×
Q4 24
-1.25×
Q3 24
-0.59×
Q2 24
Q1 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons